Amantadine The journey from fighting flu to treating Parkinson disease

被引:179
作者
Hubsher, G. [1 ]
Haider, M. [1 ]
Okun, M. S. [1 ]
机构
[1] Ctr Movement Disorders & Neurorestorat, Dept Neurol, Gainesville, FL USA
关键词
ANTIVIRAL ACTIVITY;
D O I
10.1212/WNL.0b013e31824e8f0d
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To explore how amantadine transitioned from an anti-flu drug to antiparkinsonian agent. Methods: A review of the historical literature on the use of amantadine from 1966 to the present was performed. Results: Amantadine was originally introduced and utilized as an antiviral medication. A single patient noticed relief in her Parkinson disease (PD) symptoms after taking amantadine for a flu infection, and this observation sparked an interest, and several important studies that eventually led to a new drug indication. Conclusion: Amantadine has over the years fallen out of favor as a drug to address influenza infection; however, it has become part of the arsenal utilized for early symptomatic treatment of PD, as well an option for treating dyskinesia. Neurology (R) 2012;78:1096-1099
引用
收藏
页码:1096 / 1099
页数:4
相关论文
共 14 条
  • [1] Ban Thomas A, 2006, Dialogues Clin Neurosci, V8, P335
  • [2] Centers for Disease Control and Prevention, CDC REC US AM RIM TR
  • [3] STUDIES ON ANTIVIRAL ACTIVITY OF AMANTADINE HYDROCHLORIDE
    COCHRAN, KW
    MAASSAB, HF
    TSUNODA, A
    BERLIN, BS
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1965, 130 (A1) : 432 - +
  • [4] ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE ( AMANTADINE )
    DAVIES, WL
    HOFFMANN, CE
    PAULSHOCK, M
    WOOD, TR
    HAFF, RF
    GRUNERT, RR
    WATTS, JC
    HERMANN, EC
    NEUMAYER, EM
    MCGAHEN, JW
    [J]. SCIENCE, 1964, 144 (362) : 862 - &
  • [5] Elliott J, 1979, JAMA, V242, P2387, DOI 10.1001/jama.242.22.2383
  • [6] JACKSON G G, 1963, Antimicrob Agents Chemother (Bethesda), V161, P703
  • [7] PANEL URGES WIDE USE OF ANTI-VIRAL DRUG
    MAUGH, TH
    [J]. SCIENCE, 1979, 206 (4422) : 1058 - 1060
  • [8] POSKANZER DAVID C., 1961, TRANS AMER NEUROL ASSOC, V86, P234
  • [9] Non-motor aspects of Parkinson's disease
    Rezak, Michael
    Boelen, Miriam
    Dubow, Jordan S.
    Freedom, Thomas
    Reese, Susan L.
    Mercury, Michael G.
    Tschan, Whitney
    Kehoe, Reid
    Kuecler, Amy
    Grujic, Zoran
    [J]. DM DISEASE-A-MONTH, 2007, 53 (05): : 259 - 308
  • [10] Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
    Sawada, Hideyuki
    Oeda, Tomoko
    Kuno, Sadako
    Nomoto, Masahiro
    Yamamoto, Kenji
    Yamamoto, Mitsutoshi
    Hisanaga, Kinya
    Kawamura, Takashi
    [J]. PLOS ONE, 2010, 5 (12):